Israeli, the former President and CEO of Enzymotec, will join Dr. Reddy's on April 2 as COO and Global Head of Generics & PSAI. He succeeds Abhijit Mukherjee, who is retiring on March 31, following a 15-year career with the company.
In a career spanning over 25 years, Israeli has held leadership positions that have contributed significantly to the performance of companies he worked for, said a statement by the Hyderabad-based company.
Prior to Enzymotec, he completed 23 years with Teva Pharmaceuticals Limited, where he held several positions of responsibility including Vice President, Marketing & Sales for North America, Vice President Asia Operations, President Teva API, Group Executive Vice President, Head of Global Quality, and President & CEO Growth Markets.
Dr. Reddy's Co-Chairman & CEO, G.V. Prasad said that Israeli is an accomplished leader with a proven track record of achievement. "His knowledge and experience from leading pharmaceutical businesses of scale will be valuable for our future growth," he said.
(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)
